Advertisement
more top stories »

Drugs

— Medical

FDA ticks off first drug to treat radiation sickness after nuclear disasters

By - May 25, 2015 1 Picture

A drug long-used to counter the negative effects of chemotherapy has won US Food and Drug Administration (FDA) approval for use in treating the nasty effects of exposure to radiation following a nuclear disaster. Known commercially as Neupogen, the drug has been shown to work by shielding the body's white blood cells to heighten a patient's chances of survival.

Read More
— Medical

Magnetic nanoparticles open blood-brain barrier for delivery of therapeutic molecules

By - March 26, 2015 1 Picture
The blood-brain barrier is a highly selective semipermeable barrier running inside almost all vessels in the brain that lets through water, some gases and a few other select molecules, while preventing potentially toxic elements in the blood from entering the brain. Researchers from the University of Montreal, Polytechnique Montréal, and CHU Sainte-Justine say that currently 98 percent of therapeutic molecules are also blocked by the barrier, but they have developed a technique using magnetic nanoparticles that opens the door for such molecules, thereby also opening the door to new treatments for brain diseases. Read More
— Robotics

"Robot scientist" Eve to save time and money in drug development

By - February 7, 2015 1 Picture
Modern pharmaceuticals are a wonder of our age, but they also take years to develop at incredible cost. To shorten development time and increase economy, scientists at the Universities of Cambridge and Manchester have built Eve, an artificially-intelligent "robot scientist" that is not only faster and cheaper than its human counterparts, but has already identified a compound that could be used to fight malaria. Read More
— Medical

Newly-discovered compound gives hope in fight against antibiotic-resistant bacteria

By - January 8, 2015 1 Picture
Over the past quarter century, many pharmaceutical companies have largely turned their backs on the quest to develop new antibiotics, blaming difficulties surrounding the clinical trials process and turning their attention to the more profitable development of so-called "lifestyle drugs." One company bucking the trend is NovoBiotic Pharmaceuticals, which has announced the discovery of a new class of antibiotic that holds promise for treating drug-resistant superbugs. Read More
— Medical

3D-printed tumor replicas to better measure doses of cancer-fighting drugs

By - December 18, 2014 1 Picture
Administering the correct dosages to fight cancerous tumors can be a difficult balancing act. Too much of the radioactive drugs can cause harm to healthy tissue, but not enough will see the cancer cells survive and continue to spread. But a new technique developed at The Institute of Cancer Research in London may afford doctors an unprecedented level of accuracy in performing radiotherapy, using 3D-printed replicas of a patient’s organs and tumors to better determine how much radiation a tumor has received. Read More
— Medical

Toxin-producing stem cells fight brain tumors where it matters most

By - October 27, 2014 1 Picture
When it comes to new tumor-fighting treatments, it’s often as much about location, location, location as it is the actual drug interaction. Cytoxin-producing stem cells produced by scientists at Harvard University lodge at the site of brain tumor removal to continually attack remaining tumor cells. As an alternative to drug treatments that can be invasive or ineffective, the researchers saw promising results against glioblastomas, which hold the dubious distinction of being the most common and most fatal brain cancer. Read More
Advertisement

Subscribe to Gizmag's email newsletter

Advertisement